+499.5%
MRNA vs FND
-36.4%
+535.8%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | FND | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +1.7% | -4.0% | -3.1% |
| 7D | +5.5% | -5.2% | +10.7% | +8.0% |
| 30D | +158.7% | -19.9% | +178.6% | +186.2% |
| 3M | +182.1% | +2.7% | +179.4% | +186.7% |
| 6M | +151.8% | -21.7% | +173.5% | +177.7% |
| YTD | +393.6% | -17.5% | +411.1% | +433.6% |
| 1Y | +499.5% | -39.3% | +538.8% | +615.5% |
| All | +499.5% | -36.4% | +535.8% | +615.5% |
Cumulative growth
Daily Returns
Daily percentage return beside FND.
Daily Out/Under-Performance
Portfolio return minus FND return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FND return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded FND wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling